Vista Pharma locked at 5% lower circuit on USFDA warning letter for Telangana unit News News / News 6 years ago 479 Views comments The USFDA said there have been significant violations of current good manufacturing practice regulations for finished drugs. Read more
News Market Update: HDFC Bank hits 52-week high, Tata Motors top gainer as markets hits record high News / News - 6 years ago
Comments